(Q37856884)

24 August 2017

0 references

1 reference

title

Immunizations and risk of multiple sclerosis: systematic review and meta-analysis (English)

1 reference

24 August 2017

0 references

0 references

0 references

1 reference

Mauricio F Farez

1

1 reference

PubMed ID

21431896

24 August 2017

Jorge Correale

series ordinal

2

1 reference

24 August 2017

24 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

258

1 reference

24 August 2017

7

1 reference

24 August 2017

1197-1206

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-011-5984-2

24 August 2017

0 references

cites work

Immunizations and Autism: A Review of the Literature

2 references

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

21 January 2018

12 December 2020

Epidemiology of autoimmune reactions induced by vaccination

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

A case-control study of serious autoimmune adverse events following hepatitis B immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Childhood infections as risk factors for multiple sclerosis: Belgrade case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Risk factors of multiple sclerosis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Hepatitis B vaccination and the risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

No increase in demyelinating diseases after hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Influenza virus vaccination of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Risk factors for multiple sclerosis: a case-control study in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Viral infection in patients with multiple sclerosis and HLA-DR matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Clinical evaluation of possible etiologic factors in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Geographic variation of MS incidence in two prospective studies of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Cigarette smoking and the progression of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

The risk of relapses in multiple sclerosis during systemic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Prospective study on the relationship between infections and multiple sclerosis exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Association between parasite infection and immune responses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Tetanus vaccination and risk of multiple sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Cumulative meta-analysis of therapeutic trials for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

CNS demyelination and quadrivalent HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Acute disseminated encephalomyelitis following vaccination against human papilloma virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5984-2

Swine-influenza vaccination in multiple sclerosis

21 January 2018

1 reference

12 December 2020

Multiple sclerosis and vaccination

1 reference

12 December 2020

Swine Influenza Vaccination in Patients With Multiple Sclerosis

1 reference

12 December 2020

Grading quality of evidence and strength of recommendations

1 reference

12 December 2020

The Environment and Disease: Association or Causation?

1 reference

12 December 2020

Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study

1 reference

12 December 2020

Risk factors in multiple sclerosis: tuberculin reactivity, age at measles infection, tonsillectomy and appendectomy

1 reference

12 December 2020

Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls.

1 reference

12 December 2020

A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination?

1 reference

12 December 2020

Multiple sclerosis in India: a case-control study of environmental exposures

1 reference

12 December 2020

Longitudinal myelitis associated with yellow fever vaccination

1 reference

12 December 2020

Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis

1 reference

12 December 2020

Multiple sclerosis after hepatitis B vaccination in a 16-year-old patient

1 reference

12 December 2020

10.1007/S00415-011-5984-2

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21431896